News
Vor Bio (NASDAQ:VOR) stock soars 100% with a $175M funding boost and a major autoimmune therapy licensing deal. Read more here.
Shares of Vor Bio are up 120% in pre-market trade on Thursday. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do ...
Less than two months after Vor Bio telegraphed a strategic review, the former cell therapy biotech has made a surprise comeback with a potential $4 billion deal licensing a China-made autoimmune ...
The Central Bank of the UAE has outlined the do's and don'ts of the new dirham symbol and how it will affect daily payments.
Bank of Montreal ("BMO") today announced its plan to change the ticker symbol for the MicroSectors™ FANG+™ 3× Leveraged ETNs due February 17, 2045, CUSIP: 063679385 (the "ETNs"). The ETNs are ...
Ever wondered what the power symbol actually means? It’s more than just a button -- discover the surprising history behind this iconic design.
Uncover the fascinating history behind medical symbols like the Caduceus and the Rod of Asclepius in healthcare.
France commends the May 12th ruling by the Council of the International Civil Aviation Organization (ICAO) in the case brought by Australia and the Netherlands against Russia in the downing of flight ...
ICAO is a UN body with 193 member states that decides whether countries have violated the Convention on International Civil Aviation, which requires that member states "refrain from resorting to ...
The ICAO council has ruled that Russia is responsible for the downing of Malaysia Airlines flight MH17 over Ukraine in 2014.
Vor Biopharma (NASDAQ:VOR) stock tumbles as plans to find strategic alternatives lead to downgrades on Wall Street firms, Stiflel and Baird. Read more here.
Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results